BMW Print E-mail
The BMW Group focuses on the manufacturing and distribution of automobiles and motorcycles. The BMW Group has 23 production and assembly plants, 34 sales subsidiaries, a research and development network and worldwide market presence (May 2009).

Goal

Building an HIV/AIDS workplace programme that addresses BMW South Africa’s specific context.

Key questions

1. Is an un-linked prevalence survey necessary to motivate the creation of a comprehensive HIV/AIDS programme?
2. How can BMW extend this programme to suppliers and contractors when those companies are often much smaller than BMW?
3. How can BMW SA increase the number of HIV-positive employees enrolled in the insurance scheme’s comprehensive treatment programme including anti-retrovirals?

Programme description

BMW South Africa developed its HIV/AIDS programme through a multi-stakeholder HIV/AIDS committee to address needs identified in its 2001 KAP assessment.
  • BMW South Africa developed its HIV/AIDS policy in December 2000 and has on a regular basis kept it updated, with the latest policy being effective on 1 May 2009. The policy was developed by the HIV/AIDS committee and is chaired by the plant manager, who is a board member. It is also composed of representatives from the union, finance, human resources, medical services, management and other interested parties.
  • BMW South Africa built its prevention and awareness programme around training, peer educators, condom distribution, the treatment of syndromic sexually transmitted infections (STIs), events, workshops, forums and industrial theatre.
  • The VCT project was launched in 2002 with a re-test campaign started in 2008 and completed in 2009, resulting in 76% of employees knowing their status.

HIV-positive employees gain access to BMW’s comprehensive care, support and treatment programme, including access to Highly Active Anti-Retroviral Treatment (HAART).

Click here to view the full document.
Click here to view BMW HIV/AIDS Policy.